Sagimet Biosciences Presents at Keystone Symposium

Sagimet Biosciences is presenting its research at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium. The company, focused on developing treatments for metabolic and inflammatory diseases, will share findings through poster and oral presentations. This participation highlights Sagimet's commitment to advancing scientific understanding in its therapeutic areas. The symposium provides a platform for researchers to discuss cutting-edge developments and foster collaboration within the scientific community.